Zenas BioPharma (ZBIO) Operating Leases (2023 - 2026)

Zenas BioPharma (ZBIO) posted quarterly Operating Leases of $77000.0 for Q1 2026, down 75.71% year-over-year from $317000.0 in Q1 2025, and down 63.51% quarter-over-quarter from $211000.0 in Q4 2025.

Zenas BioPharma (ZBIO) Operating Leases (2023 - 2026) Analysis & Trends

Zenas BioPharma's Operating Leases history runs 4 years deep, the most recent figure standing at $77000.0 for Q1 2026.

  • In Q1 2026, Operating Leases fell 75.71% year-over-year to $77000.0; the TTM figure through Mar 2026 stood at $77000.0 (down 75.71% YoY), while the FY2025 annual figure was $211000.0, down 3.21% from the prior year.
  • Operating Leases for Q1 2026 stood at $77000.0, down from $211000.0 in the prior quarter.
  • The five-year high for Operating Leases was $317000.0 in Q1 2025, with the low at $77000.0 in Q1 2026.
  • The 4-year median for Operating Leases is $215000.0 (2025), against an average of $210714.3.
  • The sharpest annual moves came in 2025 and 2026: Operating Leases fell 3.21% in 2025, then plunged 75.71% in 2026.
  • Zenas BioPharma's Operating Leases stood at $257000.0 in 2023, then declined by 15.18% to $218000.0 in 2024, then retreated by 3.21% to $211000.0 in 2025, then sank by 63.51% to $77000.0 in 2026.
  • Business Quant data shows ZBIO's Operating Leases at $77000.0 in Q1 2026, $211000.0 in Q4 2025, and $180000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Zenas BioPharma 1.87 Bn 748.44 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 22,000.00
Mar 31, 2026 77,000.00
Dec 31, 2025 211,000.00
Sep 30, 2025 180,000.00
Jun 30, 2025 215,000.00
Mar 31, 2025 317,000.00
Dec 31, 2024 218,000.00
Dec 31, 2023 257,000.00